Myocardial infarction and sudden cardiac death are frequently the first manifestation of coronary artery disease. For this reason, screening of asymptomatic coronary atherosclerosis has become an attractive field of research in cardiovascular medicine. Necropsy studies have described histopathological changes associated with the development of acute coronary events. In this regard, thin-cap fibroatheroma has been identified as the main vulnerable coronary plaque feature. Hence, many imaging techniques, such as coronary computed tomography, cardiac magnetic resonance or positron emission tomography, have tried to detect noninvasively these histomorphological characteristics with different approaches. In this article, we review the role of these diagnostic tools in the detection of vulnerable coronary plaque with particular interest in their advantages and limitations as well as the clinical implications of the derived findings. 
INTRODUCTION
Atherosclerosis constitutes the leading cause of morbidity and mortality in the developed countries, mostly secondary to acute coronary syndromes (ACS) [1] . Moreover, the progressive aging of the population forecasts an exponential growth of the prevalence of cardiovascular disease [2] . In this clinical scenario, detection of patients at risk of suffering an ACS has become one of the major goals in cardiology. Traditional cardiovascular risk factors have been extensively used for this aim. Nevertheless, they fail to anticipate the occurrence of an ACS, especially in certain popula tions [3, 4] , so myocardial infarction and sudden cardiac death (SCD) are frequent first manifestations of coronary disease. This situation has boosted the interest in subclinical detection of atherosclerosis. In this regard, quantification of calcium score with coronary computed tomography (CCT) [5] as well as ultrasound evaluation of carotid atherosclerosis [6, 7] have demonstrated their utility for cardiovascular risk reclassification [8, 9] . In any case, in spite of a very common detection of coronary atherosclerosis in autopsy series among young adults [10] the incidence of ACS in this population is very low [1] . Thus, the onus should be shifted onto the detection of lesions that are prone to develop a coronary event.
VULNERABLE CORONARY PLAQUE: DEFINITION, HISTOPATHOLOGICAL FEATURES AND RATIONALE FOR NONINVASIVE DIAGNOSIS
Classical studies supported that ACS were caused mainly by lesions with severe stenosis [11] ; however, PROSPECT trial [12] , a prospective intravascular ultra sound (IVUS) and virtual histology (VH) followup of nonculprit lesions after ACS, revealed that most of the events are derived from angiographically mild stenosis (< 50%). Again autopsy studies have provided relevant information regarding the atherosclerotic plaque characteristics in culprit lesions. The most frequent presentation is plaque rupture, followed by plaque erosion [13] . Rarely (2%7% of the cases) the ACS are related with a calcified nodule morphology [14] . These lesions are unfailingly associated with a variable amount of thrombus [15] . Given that plaque rupture is the most common substrate of acute coronary events, vulnerable plaques are defined as lesions at the greatest risk of rupture, with subsequent thrombosis or rapid stenosis progression (Table 1 ) [16] . Therefore, they are also named highrisk or thrombosisprone plaques. When ruptured plaques leading to acute coronary events were studied in necropsies, they usually presented a large necrotic core with a thin overlying fibrous cap together with inflammatory cells and little calcification [17] . Moreover, unlike lesions related to stable disease, these plaques showed expansive or positive remodeling not causing significant narrowing of the coronary lumen [18] . Thus, plaques with these histomorphologic features but intact fibrous cap, named thincap fibroatheroma (TCFA), were assumed to be prone to rupture. This concept was evaluated in a detailed histologic analysis of atherosclerotic plaques from a large series of patients who suffered SCD [19] . This study established a relevance hierarchy of morphological features that may influence plaque rupture. In a general analysis a thin fibrous cap (< 84 μm) was able to exclude stable lesions. Interestingly, among TCFA with a cap thickness < 54 μm cross section area stenosis was most likely < 74%. Finally, when fibrous cap thickness was not considered in the analysis, inflammation, characterized by macrophage plaque infiltration, as well as a large necrotic core emerged as typical features of potentially unstable lesions. In this regard, aforementioned PROSPECT trial [12] was able to confirm these findings in vivo with IVUS. In this study plaque burden ≥ 70%, minimal luminal area ≤ 4 mm 2 and TCFA characteristics on VH were independently associated with subsequent major adverse cardiovascular events (MACE) derived from nonculprit lesions. Some considerations should be kept in mind to understand the clinical relevance of vulnerable plaque detection. All the plaque ruptures do not inevitably cause an ACS [20] , whereas disruption and healing is the typical mechanism of plaque stenosis growth [21, 22] . Thus, a perfect storm scenario, with confluence of plaque vulnerability, inflammatory state, platelet activation and impaired fibrinolysis, is necessary for ACS occurrence [23] . However, given that substrate presence is a conditio sine qua non and the other involved factors (homeostasis disbalance and thrombogenicity) are difficult to esta blish and/or variable in time, noninvasive detection of vulnerable plaques may be clinically relevant [24] , especially in very high risk patients [25] . Hence, in this paper we review the different noninva sive diagnostic tools to evaluate vulnerable coronary plaques, with a detailed description of the relevant information they provide as well as their particular strengths and limitations (Table 2) . We focus specially on the technique with the greatest evidence in this field, CCT, mentioning other available imaging tools with promising perspective such as cardiac magnetic resonance (CMR) imaging and positron emission tomo graphy (PET).
CCT

CCT general information with predictive value
CCT not only provides information about the presence
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September 26, 2016|Volume 8|Issue 9| WJC|www.wjgnet.com of significant stenoses with a high diagnostic accuracy [26] ( Figure 1 ) but also allows a sensitive noninvasive direct evaluation of coronary atherosclerosis [27] . Coronary calcium score determination [28] as well as non-calcified plaque detection, even in the absence of significant stenosis [2931] , have demonstrated their value to predict MACE. Moreover, a large and systematic metaanalysis highlighted the relevance of luminal stenosis severity assessment with CCT [32] , showing an increasing risk of the composite endpoint of cardiac death or myocardial 
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Coronary plaque characterization with CCT
Certainly, the most relevant information is derived from the direct evaluation of coronary plaque with CCT. By consensus [35] the lesions are classified in 3 categories:
Noncalcified, calcified and mixed plaques ( Figure  2 ). In this regard, for a further assessment of CCT infarction for absence (0.04%), nonobstructive (1.29%) and obstructive (6.53%) coronary artery disease. It has shown a particular utility in chest pain evaluation at the emergency room [33] . There is also data supporting the capacity of CCT to evaluate coronary anatomy to determine the best revascularization strategy [34] . erosions leading to ACS from stable lesions. Lastly, CCT accuracy for plaque composition characterization was also evaluated with nearinfrared spectroscopy (NIRS), showing a good correlation of plaque burden and non calcified plaque area and density with cholesterol deposition in the coronary wall [27] . Thereby, even with first generation 16rows scan ners, culprit lesion characteristics could be evaluated in ACS [44] . When these lesions were compared with those in patients with stable angina, positive expansive remodeling, low attenuation (< 30 HU) noncalcified plaques and spotty calcification were detected more frequently ( Figure 3) . Furthermore, the combination of these three features increased the positive predictive value to 95%. These findings were corroborated with a prospective multimodal imaging protocol in acute coronary events [45] . Again lower radiological density with lower calcium score and larger remodeling index were more common in culprit lesions. Interestingly, these plaque characteristics were confirmed with IVUS and VH.
CCT CMR PET
Beyond the classical tools for CCT analysis, there are new approaches with promising results in coronary plaque evaluation. Fujimoto et al [46] showed that the presence of delayed plaque enhancement in serial CCT acquisition was associated with highrisk plaque features. They hypothesized that this finding may be explained by plaque neovascularization and/or inflammation. In the same direction, a contrast agent formed by iodinated nanoparticles has been probed to detect macrophages in a preclinical model of atherosclerosis [47] . accuracy in coronary plaque qualitative analysis, head tohead comparisons with VH have been performed. Pundziute et al [36] found a good correlation between both diagnostic tools in plaque characterization, with more fibrotic and fibrofatty components in non calcified plaque. Besides, the majority of TCFA in IVUS corresponded to mixed plaques in CCT. Hereof, Choi et al [37] established that plaques with > 10% necrotic core by VH showed significantly lower HU values in CCT. All the studies have shown a good agreement in noncalcified plaque quantification between both techniques [3840] . However, there were contradictory results in plaque composition analysis using predefined Hounsfield unit (HU) ranges, due to overlapping in these values [38, 40] . On the other hand, optical coherence tomography (OCT) has also been used as reference intravascular imaging technique. Kashiwagi et al [41] divided plaques in TCFA and nonTCFA according to OCT findings and studied the CCT plaque characteristics. Positive remodeling, lower attenuation values and ring like enhancement (napkinring sign) on CCT were significantly more common in OCT-derived TCFA lesions. The later feature showed a good diagnostic accuracy for highrisk plaque detection and was independently associated with acute events. Moreover, napkinring sign has been independently associated with necrotic/lipid core area, noncore plaque area and total vessel area in postmortem histopathological correlation [42] . However, although the presence of low attenuation and positive remodeling in CCT could identify rupture plaques in another study [43] , they failed to differentiate plaque differences in lumen volume and remodeling index changes between the groups. Thus, CCT may play a role in evaluation of the response to lipidlowering drugs.
Limitations of CCT in coronary plaque evaluation
Despite the promising data, CCT is far from be free of limitations in vulnerable coronary plaque analysis. First, precise definition of plaque components is hampered by inherent limited spatial resolution of this imaging technique. Thus, results of non-calcified plaque quantification may be inconsistent [39, 57] . Moreover, as previously mentioned, CCT plaque characterization is restricted by the overlap in radiological attenuation ranges for the different types of lesions [58, 59] (Figure   4 ). In this regard, dualsource CCT, whose 2 different energies provide differing attenuation of materials, have shown to improve differentiation of necrotic core and fibrous plaque ex vivo [60] . Nevertheless, these results worsened when applied in vivo [38, 60] . Thus, CCT acquisition technology needs to be refined to establish a generalizable HUbased categorization for accurate evaluation of components of the coronary plaque. Second, heavily calcified plaque may obscure detailed plaque evaluation due to partial volume effect. Finally, as previously mentioned, CCT has failed to detect plaque erosion [43] , which constitutes the second more frequent presentation of culprit lesions [13] .
CMR
CMR not only allows a precise ventricular volume quantification [61] and myocardial tissue characteri zation [62, 63] , but also is able to detect the presence of significant (> 50%) coronary atherosclerosis with similar accuracy than CCT [64, 65] (Figure 5 ). In any case, in CMR spatial resolution is directly proportional to scan time. Thus, the necessary high resolution for coronary imaging carries an inherent increased susceptibility to motion artifacts [66] . The most effective measure to optimize image resolution without affecting artifact susceptibility is to reduce the field of view [67] , which is difficult if a whole coronary tree analysis is pursued. Apart from that, several strategies have been implemented to avoid aforementioned limitation: Techniques to accelerate image acquisition [68, 69] , cardiac [70] and respiratory [71] motion compensation and new sampling methods [72, 73] . However, even with the last technical advances a whole heart coronary CMR angiography still takes at least 5 min [74, 75] , which limits its translation to clinical practice. Although the aforementioned limitations make the acquisition challenging, noncontrast blackblood sequences have shown a good correlation with IVUS in luminal area and coronary plaque burden deter mination [76, 77] . Interestingly, methemoglobin produced during clot maturation has the potential of shortening T1 relaxation time, which allows coronary thrombus detection with T1weighted sequences [78, 79] . The dia gnostic accuracy of this noninvasive technique was
Prognostic relevance of plaque characterization with CCT
The hypothesis that aforementioned morphological patterns are able to identify thrombosisprone plaques was evaluated in prospective studies. Motoyama et al [48] analyzed for the first time CCT plaque characteristics associated with the incidence of ACS in the follow up. In this study, the presence of positive remodeling and/or low attenuation plaque was independently associated with ACS (HR = 22.8; P < 0.001) ( Figure  3 ). Napkinring sign is another feature that has been associated with thrombosisprone plaque. In a large series this sign was the strongest predictor of ACS among the vulnerable plaque characteristics [49] . On the other hand, a casecontrol study [50] demonstrated that when a semiautomated quantitative analysis of CCT was implemented, total and relative plaque volume and noncalcified plaque were significantly higher in patients who suffered an acute coronary event. This method of evaluation also had additive value to classical cardiovascular risk factors and conventional CCT reading for ACS prediction. Nevertheless, on top of the some methodological limitations [51] , there is contradictory results in large prospective series. Among patients derived from ROMICAT II cohort [52] , acute chest pain in emergency room, presence of a least one of high risk features (positive remodeling, low attenuation, spotty calcification and napkin-ring sign) was an independent predictor of ACS, even after adjustment by clinical risk factors and > 50% or > 70% stenosis [52] . Conversely, when stable patients were evaluated, plaque feature analysis, although improved predictive accuracy, did not significantly increase model discrimination index for acute coronary events [53] . Interestingly, the relevance of highrisk plaque detection on CCT was analyzed in another important cohort from a patientbased and lesionbased perspective [54] . In the former, vulnerable plaque was independently associated with prognosis. However, presence of highrisk features failed to predict ACS in a lesionbased analysis. Additionally, when serial CCT was available, plaque progression emerged as an independent predictor of events. Putting all these data in perspective, although vulnerable plaque CCT features may predict ACS the clinical relevance of these finding still needs to be clarify.
Influence of CCT plaque characteristics in percutaneous coronary interventions outcome was evaluated as well. The incidence of slowflow phenomenon in patients with stable coronary disease was related with the presence of circumferential plaque calcification, a higher positive remodeling index and a lower plaque density in previous CCT [55] . In fact, circumferential plaque calcification showed the strongest independent association with this complication.
Finally, when CCT was used to evaluate the response to statin therapy [56] a greater decrease of total plaque volume, due to reduction in low attenuation plaque, was detected among patients under treatment, without large animals and/or humans: Fibrin-specific [8890] and elastinspecific [91] contrast agents, gadofluorine [92, 93] , albuminbinding [9496] contrast agent, and iron oxide based [97] contrast. However, due to the growing field of molecular imaging a detailed discussion of these agents exceed the scope of this review.
PET
Besides the detailed morphological characterization provided by CCT and CMR, quantification of inflam mation is a key feature in vulnerable coronary plaque evaluation. In this regard, nuclear imaging techniques have been extensively used for this purpose in atherosclerosis [98, 99] . PET is the preferred tool, due to its superior spatial resolution over single photon emission tomography (SPECT), and is usually combined with computed tomography for a better anatomical definition. Fluorodeoxyglucose (FDG) is the most widely used tracer in this field. However, coronary evaluation is hampered by the significant myocardial uptake of FDG. To override this limitation, free fatty myocardial metabolism was favored with a lowcarbohydrate high fat preparation [100] . This strategy was initially proven to detect coronary plaque inflammation [101] . Moreover, when coronary PET was evaluated in ACS as well as in stable angina proven to be high when it was evaluated against inva sive coronary angiography [80] and OCT [81] (Figure 6 ).
On the other hand, in a headtohead comparison with CCT the presence of high intensity lesions on T1 sequences was associated with features of vulnerable plaque, such as positive remodeling, low attenuation and spotty calcification [82] . Moreover, this CMR finding was also associated with prognosis: Higher incidence of slowflow phenomenon after percutaneous coronary intervention [82] , coronary events during the followup [83] , and regression of plaque in response to statin therapy [84] . Finally, T2weighted sequences have demonstrated their ability to detect coronary vessel wall edema, in probable relation with plaque neovascularization, in initial studies [85, 86] . Targeted as well as nontargeted contrast agents have been used to evaluate coronary arteries with CMR. When nonspecific gadolinium contrast is used, the presence of hyperenhancement has been linked to the severity of coronary atherosclerosis [79] . Additionally, a progressive reduction of coronary hyperenhancement has been noted in serial CMR after acute myocardial infarction [87] . Contrarily, many targeted contrast agents, directed to specific components of the plaque, are currently under investigation. Among them some have already reached positive data for coronary evaluation in Framingham risk score, prior cardiovascular events and angina. Lastly, new tracers targeted against other markers of inflammation such as macrophage infiltration (11CPK11195 [104] and 68GaDOTATATE [105] ) have been successfully tested.
CONCLUSION
Noninvasive imaging tools have shown their capacity to detect features related with vulnerable coronary after stent implantation, a higher FDG uptake was noted not only in the culprit lesions but also in the left main and ascending thoracic aorta of the patients with acute coronary events (Figure 7 ) [102] . This suggests the presence of spread arterial wall inflammation in the former group. Conversely, Dweck et al [103] demonstrated the ability of the new tracer 18Fsodium fluoride to detect coronary atherosclerosis without the limitation of myocardial metabolism artifact. Increased uptake was also associated with coronary calcium score,
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Figure 5 Unenhanced Whole-Heart coronary cardiac magnetic resonance angiography. Correlation of unenhanced whole-heart coronary CMR angiography (A, maximum intensity projection image, and B, volume-rendered image) with invasive coronary angiography (C) in a in a 50-year-old male patient with chest pain on effort. Note the presence of significant stenosis in proximal LAD (arrows). Adapted with permisssion from Nagata et al [75] . LAD: Left anterior descending coronary artery; D1: First diagonal branch; CMR: Cardiac magnetic resonance. CCTA (A) showed a noncalcified plaque in LAD causing significant stenosis. When noncontrast T1-weighted CMR imaging was performed (B) a hyperintense lesion was detected. Afterwards, CMR images were fused with CCTA (C and D) and this lesion was found to correspond with the previously described coronary stenosis. Interestingly, during the subsequent coronary angiography it showed a large lipid component in IVUS (E) as well as OCT (F). Adapted with permission from Asaumi et al [106] . LAD: Left anterior descending coronary artery; CCTA: Coronary computed tomography; CMR: Cardiac magnetic resonance; IVUS: Intravascular ultrasound; OCT: Optical coherence tomography; PMR: Plaque to myocardium signal intensity ratio.
plaque. CCT has been largely tested with this aim. Certain plaque characteristics, such as positive remo deling, low attenuation, spotty calcification and napkinring sign, have been systematically associated with ACS occurrence. Regarding CMR, results of plaque morphology characterization are similar than CCT but the inherent acquisition limitations hampered its extension to clinical practice. Moreover this technique allows tissue characterization of the coronary plaques through T1 and T2weighted sequences and contrast enhanced imaging. Finally, PET has emerged as a promising molecular imaging technique being able to detect coronary inflammation and even macrophage infiltration in vivo. In any case, given that the presence of vulnerable plaque features is not irredeemably linked to the occurrence of an ACS, larger studies are needed to clarify the patient subgroup that may benefit from noninvasive detection of highrisk plaques. This aspect is of special interest due to the large population that may be the target of a noninvasive imaging strategy for acute coronary events prevention. In this regard, cost effectiveness should also be evaluated carefully in the future. 
